Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1032201

C1=Cc2cc3ccc(cc4nc(cc5ccc(cc1n2)[nH]5)C=C4)[nH]3.Cl

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.41
▸ STAT1 P42224 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5165821 1.00 STAT3 (0.41) STAT3STAT1
Hydrochloric Acid SCHEMBL27579987 1.00 STAT3 (0.41) STAT3STAT1
Hydrochloric Acid SCHEMBL29883296 1.00 STAT3 (0.41) STAT3STAT1
Hydrochloric Acid SCHEMBL27597695 1.00 STAT3 (0.41) STAT3STAT1
Hydrochloric Acid SCHEMBL6418305 1.00 STAT3 (0.41) STAT3STAT1
Hydrochloric Acid SCHEMBL6418298 1.00 STAT3 (0.41) STAT3STAT1
Hydrochloric Acid SCHEMBL8202776 1.00 STAT3 (0.41) STAT3STAT1
Hydrochloric Acid SCHEMBL9238234 0.97 STAT3 (0.40) STAT3STAT1
Hydrochloric Acid SCHEMBL11327619 0.97 STAT3 (0.40) STAT3STAT1
Hydrochloric Acid SCHEMBL28132200 0.97 STAT3 (0.40) STAT3STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4719328-A1 BLEACHING MEDIUM COMPRISING A PHENALENONE Wella Germany GmbH (DE) 2026-04-08 — — EP claimed
WO-2024246147-A1 BLEACHING MEDIUM COMPRISING A PHENALENONE WELLA GERMANY GMBH (DE) 2024-12-05 — — WO claimed
CN-118398831-A Preparation method of high-durability oxygen reduction electrocatalyst with iron-nitrogen-carbon supported platinum-manganese alloy particles 大连理工大学 2024-07-26 — — CN claimed
CN-117030019-B Preparation method of ZIF-8@dye nano color sensor and application of ZIF-8@dye nano color sensor in food quality evaluation 江苏大学 2024-07-12 — — CN claimed
CN-115845922-B Visible light catalytic CO 2 Metal-organic framework composite material with cycloaddition reaction and preparation method and application thereof 中山大学 2023-11-21 — — CN claimed
CN-115141179-A Novel benzo heterocyclic derivatives, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2022-10-04 — — CN claimed
CN-106111196-B A kind of preparation method and application of ferriporphyrin chloride/methylene blue@metal organic framework composite electrodes 青岛大学 2018-08-07 — — CN claimed
CN-107072884-A The root canal disinfection of microvesicle based on photochemical activation 西亚克特有限责任公司 2017-08-18 — — CN claimed
CN-106111196-A A kind of preparation method and application of iron porphyrin chloride/methylene blue@metallic organic framework composite electrode 青岛大学 2016-11-16 — — CN claimed
EP-0232857-A2 Modified haem, process for its production and use SUNTORY LIMITED (JP) 1987-08-19 — — EP claimed
CN-122039076-A Preparation method of 2-methyl sulfoxide pyrimidine derivative 石河子大学 2026-05-15 — — CN disclosed
EP-4727696-A1 SYNTHESIS OF CARBONYLATION CATALYST FROM COBALT SALTS Novomer, Inc. (US) 2026-04-22 — — EP disclosed
EP-4719328-A1 BLEACHING MEDIUM COMPRISING A PHENALENONE Wella Germany GmbH (DE) 2026-04-08 — — EP disclosed
CN-114994025-B Beef freshness rapid detection method based on olfactory visualization chip 浙江大学 2025-12-23 — — CN disclosed
EP-3225112-B2 PHOTOSENSITISER DISPERSION AND USE OF THE SAME TRIOPTOTEC GMBH (DE) 2025-03-26 — — EP disclosed
WO-2004110451-A1 COMBINATIONS FOR OPIOID-BASED TREATMENT OF PAIN COMPRISING 1-(1,2-DISUBSTITUTED PIPERIDINYL)-4-SUBSTITUTED PIPERAZINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2004-12-23 — — WO disclosed
WO-2004110415-A2 SUBSTITUTED 1, 4-DI-PIPERIDIN-4-YL-PIPERAZINE DERIVATIVE COMBINED WITH AN OPIOID ANALGESIC AND THEIR USE FOR THE TREATMENT OF PAIN AND SIDE-EFFECTS ASSOCIATED WITH OPIOID-BASED TREATMENTS JANSSEN PHARMACEUTICA N.V. (BE) 2004-12-23 — — WO disclosed
US-6372727-B1 ADMINISTERING IRON PORPHYRIN TO TREAT AMYOTROPHIC LATERAL SCLEROSIS; TREATING OXIDATIVE INJURY RELATED TO PEROXYNITRITE UAB RESEARCH FOUNDATION 2002-04-16 — — US disclosed
US-6331438-B1 FOR DETECTING AND QUANTIFYING BIOLOGICAL, CHEMICAL, AND PHYSICAL ANALYTES IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2001-12-18 — — US disclosed
US-4618737-A OLIGOMERIZATION OF LOWER OLEFINS; POLYMERIZATION OF HEAVY FRACTION MOBIL OIL CORPORATION (US) 1986-10-21 — — US disclosed
Send feedback